A. Schobel

A. Schobel

Chief Tech/Sci/R&D Officer presso AQUESTIVE THERAPEUTICS, INC.

Patrimonio netto: 4 M $ in data 31/03/2024

68 anni
Health Technology
Process Industries
Technology Services

Profilo

A.
Mark Schobel
is currently the Director at Cecilian Partners, LLC.
He is also the Chief Technology & Innovation Officer at Aquestive Therapeutics, Inc. since 2015.
Additionally, he holds the position of Head-Public Relations at MonoSol LLC.
In the past, Mr. Schobel worked as the Principal at Pharmaceutical Formulations, Inc. and Warner-Lambert Co. He was also the Global Head-New Technology at Novartis Corp.
from 2001 to 2005.
Furthermore, he held the position of Principal at Reed & Carnrick Pharmaceuticals.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
15/03/2024 984 476 ( 1.09% ) 4 M $ 31/03/2024

Posizioni attive di A. Schobel

SocietàPosizioneInizio
AQUESTIVE THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 01/11/2014
MonoSol LLC /Laundry Bag Business/ Investor Relations Contact -
Director/Board Member -
Tutte le posizioni attive di A. Schobel

Precedenti posizioni note di A. Schobel

SocietàPosizioneFine
Corporate Officer/Principal -
Reed & Carnrick Pharmaceuticals Corporate Officer/Principal -
Pharmaceutical Formulations, Inc. Corporate Officer/Principal -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di A. Schobel

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di A. Schobel

Relazioni

61

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
AQUESTIVE THERAPEUTICS, INC.

Health Technology

Aziende private6
Pharmaceutical Formulations, Inc.

Health Technology

Health Technology

Health Technology

MonoSol LLC /Laundry Bag Business/

Process Industries

Reed & Carnrick Pharmaceuticals

Technology Services

Vedi le connessioni aziendali